Product Information
ARISTADA ER 441 MG/1.6 ML SYRN is a brand product labeled by Alkermes, Inc., priced at $991.8102 per ML under NDC 65757040103. Its NADAC has been published 484 times since Mar 22, 2017.
Strength
441 mg/1.6mL
Manufacturer
Alkermes, Inc.NDC
65757040103
Classification
Brand
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Last Updated
6/17/2026
Active Ingredients
ARIPIPRAZOLE LAUROXILApproval Type
New Drug (NDA)
FDA Application
NDA207533On Market Since
10/5/2015
Pharmacological Classes
Price Statistics
The NADAC for ARISTADA ER 441 MG/1.6 ML SYRN has been published 484 times since Mar 22, 2017, and over the history we have for it it has risen 53.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $991.8102 per ML |
|---|---|
| All-time high | $999.5820 (May 13, 2026) |
| All-time low | $647.8787 (Mar 22, 2017) |
| 52-week high | $999.5820 |
| 52-week low | $941.0431 |
| Median price | $847.5478 |
| Average price | $836.6035 |
| Largest weekly change | +6.0% (Apr 15, 2020) |
| Weeks tracked | 484 |
| Tracking since | Mar 22, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the aripiprazole lauroxil market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ARISTADA ER 441 MG/1.6 ML SYRN?
The current National Average Drug Acquisition Cost (NADAC) for ARISTADA ER 441 MG/1.6 ML SYRN, manufactured by Alkermes, Inc., is $991.8102 per ML (NDC 65757040103), effective Jun 24, 2026.
How has the price of ARISTADA ER 441 MG/1.6 ML SYRN changed over time?
Over the history we have for it, the NADAC for ARISTADA ER 441 MG/1.6 ML SYRN has risen 53.1%. It has been tracked across 484 weekly CMS publications since Mar 22, 2017.
What are the highest and lowest recorded NADAC prices for ARISTADA ER 441 MG/1.6 ML SYRN?
Since Mar 22, 2017, the NADAC for ARISTADA ER 441 MG/1.6 ML SYRN has ranged from a low of $647.8787 (Mar 22, 2017) to a high of $999.5820 (May 13, 2026), with a median of $847.5478 per ML.
Are there cheaper alternatives to ARISTADA ER 441 MG/1.6 ML SYRN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ARISTADA ER 441 MG/1.6 ML SYRN, so no direct lower-cost alternative is listed.
Who manufactures ARISTADA ER 441 MG/1.6 ML SYRN?
ARISTADA ER 441 MG/1.6 ML SYRN (NDC 65757040103) is labeled by Alkermes, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification